International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management

[1]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[2]  S. Cummings,et al.  Strong Relation Between Muscle Mass Determined by D3-creatine Dilution, Physical Performance, and Incidence of Falls and Mobility Limitations in a Prospective Cohort of Older Men. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  M. Luedi.  Journal of Cachexia, Sarcopenia and Muscle , 2019 .

[4]  M. Izquierdo,et al.  Exercise Deficiency Diseases of Ageing: The Primacy of Exercise and Muscle Strengthening as First-Line Therapeutic Agents to Combat Frailty. , 2018, Journal of the American Medical Directors Association.

[5]  R. Ramírez-Campillo,et al.  High-speed resistance training in elderly women: Effects of cluster training sets on functional performance and quality of life , 2018, Experimental Gerontology.

[6]  Satoshi Ida,et al.  SARC-F for Screening of Sarcopenia Among Older Adults: A Meta-analysis of Screening Test Accuracy. , 2018, Journal of the American Medical Directors Association.

[7]  M. Izquierdo,et al.  Physical strategies to prevent disuse-induced functional decline in the elderly , 2018, Ageing Research Reviews.

[8]  P. Abete,et al.  Sarcopenia: assessment of disease burden and strategies to improve outcomes , 2018, Clinical interventions in aging.

[9]  M. Yamada,et al.  Chapter 4 Treatment of sarcopenia , 2018, Geriatrics & gerontology international.

[10]  H. Shimada,et al.  Chapter 2 Epidemiology of sarcopenia , 2018, Geriatrics & gerontology international.

[11]  T. Kurihara,et al.  Chapter 3 Prevention of sarcopenia , 2018, Geriatrics & Gerontology International.

[12]  H. Arai,et al.  Chapter 1 Definitions and diagnosis of sarcopenia , 2018, Geriatrics & gerontology international.

[13]  Ying Wang,et al.  Screening Sarcopenia in Community-Dwelling Older Adults: SARC-F vs SARC-F Combined With Calf Circumference (SARC-CalF). , 2018, Journal of the American Medical Directors Association.

[14]  E. Lonn,et al.  Vitamin D and progression of carotid intima‐media thickness in HIV‐positive Canadians , 2018, HIV medicine.

[15]  J. Vitale,et al.  Diagnostic imaging of osteoporosis and sarcopenia: a narrative review. , 2018, Quantitative imaging in medicine and surgery.

[16]  J. Reginster,et al.  Comparison of the performance of five screening methods for sarcopenia , 2017, Clinical epidemiology.

[17]  L. Rodríguez-Mañas,et al.  Relationship Between Sarcopenia and Frailty in the Toledo Study of Healthy Aging: A Population Based Cross-Sectional Study. , 2017, Journal of the American Medical Directors Association.

[18]  M. Cesari,et al.  Sarcopenia: An Overview on Current Definitions, Diagnosis and Treatment. , 2017, Current protein & peptide science.

[19]  A. Cruz-Jentoft.  Beta-Hydroxy-Beta-Methyl Butyrate (HMB): From Experimental Data to Clinical Evidence in Sarcopenia. , 2017, Current protein & peptide science.

[20]  C. Won,et al.  Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study. , 2018, Journal of the American Medical Directors Association.

[21]  D. Kiel,et al.  Lower Lean Mass Measured by Dual-Energy X-ray Absorptiometry (DXA) is Not Associated with Increased Risk of Hip Fracture in Women: The Framingham Osteoporosis Study , 2018, Calcified Tissue International.

[22]  J. Reginster,et al.  Quality of life in sarcopenia measured with the SarQoL®: impact of the use of different diagnosis definitions , 2017, Aging Clinical and Experimental Research.

[23]  M. Izquierdo,et al.  There are no no-responders to low or high resistance training volumes among older women , 2017, Experimental Gerontology.

[24]  P. Abete,et al.  Prevalence and Clinical Correlates of Sarcopenia, Identified According to the EWGSOP Definition and Diagnostic Algorithm, in Hospitalized Older People: The GLISTEN Study , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

[25]  R. Miralles,et al.  Prevalence of malnutrition and sarcopenia in a post-acute care geriatric unit: Applying the new ESPEN definition and EWGSOP criteria. , 2017, Clinical nutrition.

[26]  Satoshi Ida,et al.  Association Between Sarcopenia and Mild Cognitive Impairment Using the Japanese Version of the SARC-F in Elderly Patients With Diabetes. , 2017, Journal of the American Medical Directors Association.

[27]  A. Vinik,et al.  SARCOPENIA: AN ENDOCRINE DISORDER? , 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[28]  E. Freiberger,et al.  The SARC-F Questionnaire: Diagnostic Overlap with Established Sarcopenia Definitions in Older German Men with Sarcopenia , 2017, Gerontology.

[29]  Kenneth Rockwood,et al.  The Asia-Pacific Clinical Practice Guidelines for the Management of Frailty. , 2017, Journal of the American Medical Directors Association.

[30]  M. Cesari,et al.  Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study. , 2017, Journal of the American Medical Directors Association.

[31]  M. Yamada,et al.  Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. , 2017, Journal of the American Medical Directors Association.

[32]  W. Evans,et al.  Recent advances for measurement of protein synthesis rates, use of the ‘Virtual Biopsy’ approach, and measurement of muscle mass , 2017, Current opinion in clinical nutrition and metabolic care.

[33]  E. Dent,et al.  Sarcopenia and post-hospital outcomes in older adults: A longitudinal study. , 2017, Archives of gerontology and geriatrics.

[34]  A. Gossum,et al.  ESPEN guidelines on definitions and terminology of clinical nutrition. , 2017, Clinical nutrition.

[35]  K. Kamiya,et al.  Utility of SARC-F for Assessing Physical Function in Elderly Patients With Cardiovascular Disease. , 2017, Journal of the American Medical Directors Association.

[36]  M. Cesari,et al.  Biomarkers for physical frailty and sarcopenia , 2017, Aging Clinical and Experimental Research.

[37]  J. Reginster,et al.  The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action , 2016, Calcified Tissue International.

[38]  C. Szlejf,et al.  Cross-Cultural Adaptation and Validation of the Spanish-Language Version of the SARC-F to Assess Sarcopenia in Mexican Community-Dwelling Older Adults. , 2016, Journal of the American Medical Directors Association.

[39]  T. G. Barbosa-Silva,et al.  Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice. , 2016, Journal of the American Medical Directors Association.

[40]  Hisamine Kobayashi,et al.  Exercise and Nutritional Supplementation on Community-Dwelling Elderly Japanese Women With Sarcopenic Obesity: A Randomized Controlled Trial. , 2016, Journal of the American Medical Directors Association.

[41]  J. Cramer,et al.  Impacts of High-Protein Oral Nutritional Supplements Among Malnourished Men and Women with Sarcopenia: A Multicenter, Randomized, Double-Blinded, Controlled Trial. , 2016, Journal of the American Medical Directors Association.

[42]  S. Anker,et al.  Welcome to the ICD‐10 code for sarcopenia , 2016, Journal of cachexia, sarcopenia and muscle.

[43]  C. Cooper,et al.  Sarcopenia in daily practice: assessment and management , 2016, BMC Geriatrics.

[44]  L. Peng,et al.  Recent Advances in Sarcopenia Research in Asia: 2016 Update From the Asian Working Group for Sarcopenia. , 2016, Journal of the American Medical Directors Association.

[45]  G. Guyatt,et al.  GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines , 2016, British Medical Journal.

[46]  E. Hoogendijk,et al.  Frailty measurement in research and clinical practice: A review. , 2016, European journal of internal medicine.

[47]  Erik Rosendahl,et al.  Recommendations on Physical Activity and Exercise for Older Adults Living in Long-Term Care Facilities: A Taskforce Report. , 2016, Journal of the American Medical Directors Association.

[48]  J. Morley.  Frailty and Sarcopenia: The New Geriatric Giants. , 2016, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[49]  B. Iglseder,et al.  Case finding for sarcopenia in geriatric inpatients: performance of bioimpedance analysis in comparison to dual X-ray absorptiometry , 2016, BMC Geriatrics.

[50]  S. Resnick,et al.  Effects of Testosterone Treatment in Older Men. , 2016, The New England journal of medicine.

[51]  B. Clark,et al.  Resistance Exercise to Prevent and Manage Sarcopenia and Dynapenia , 2016, Annual Review of Gerontology and Geriatrics.

[52]  L. Ferrucci,et al.  SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes , 2015, Journal of cachexia, sarcopenia and muscle.

[53]  J. Morley.  Pharmacologic Options for the Treatment of Sarcopenia , 2016, Calcified Tissue International.

[54]  M. Cesari,et al.  Innovative Medicines Initiative: The SPRINT Project. , 2015, The Journal of frailty & aging.

[55]  Germin Fahim,et al.  Practice Guideline Development, Grading, and Assessment. , 2015, P & T : a peer-reviewed journal for formulary management.

[56]  Catheeja Ismail,et al.  Diagnostic ultrasound estimates of muscle mass and muscle quality discriminate between women with and without sarcopenia , 2015, Front. Physiol..

[57]  T. Hortobágyi,et al.  Dose–Response Relationships of Resistance Training in Healthy Old Adults: A Systematic Review and Meta-Analysis , 2015, Sports Medicine.

[58]  A. Gollhofer,et al.  Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men: a randomised controlled trial , 2015, British Journal of Nutrition.

[59]  L. Donini,et al.  Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. , 2015, Journal of the American Medical Directors Association.

[60]  G. Annoni,et al.  Sarcopenia and malnutrition in acutely ill hospitalized elderly: Prevalence and outcomes. , 2015, Clinical nutrition.

[61]  M. Downes,et al.  Vitamin D, muscle and bone: Integrating effects in development, aging and injury , 2015, Molecular and Cellular Endocrinology.

[62]  S. Tanni,et al.  Vitamin D serum levels are associated with handgrip strength but not with muscle mass or length of hospital stay after hip fracture. , 2015, Nutrition.

[63]  J. Morley,et al.  Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting: similarities and discrepancies. , 2015, Journal of the American Medical Directors Association.

[64]  J. Woo,et al.  Defining sarcopenia in terms of incident adverse outcomes. , 2015, Journal of the American Medical Directors Association.

[65]  F. Garcia-Garcia,et al.  Performance of the European Working Group on Sarcopenia in Older People algorithm in screening older adults for muscle mass assessment. , 2015, Age and ageing.

[66]  A. King,et al.  Light Intensity Physical Activity and Sedentary Behavior in Relation to Body Mass Index and Grip Strength in Older Adults: Cross-Sectional Findings from the Lifestyle Interventions and Independence for Elders (LIFE) Study , 2015, PloS one.

[67]  Jose M Garcia,et al.  Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials. , 2015, The Lancet. Oncology.

[68]  B. Tseng,et al.  Treatment of sporadic inclusion body myositis with bimagrumab , 2014, Neurology.

[69]  K. Nair,et al.  Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. , 2014, Clinical nutrition.

[70]  S. Anker,et al.  Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology—update 2014 , 2014, Journal of cachexia, sarcopenia and muscle.

[71]  Jeffrey R Stout,et al.  Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS) , 2014, Age and ageing.

[72]  J. Woo,et al.  Validating the SARC-F: a suitable community screening tool for sarcopenia? , 2014, Journal of the American Medical Directors Association.

[73]  Catherine Sherrington,et al.  Adherence to exercise programs for older people is influenced by program characteristics and personal factors: a systematic review. , 2014, Journal of physiotherapy.

[74]  J. Reginster,et al.  Prevalence of sarcopenia: the impact of different diagnostic cut-off limits. , 2014, Journal of musculoskeletal & neuronal interactions.

[75]  C. Higano,et al.  Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer. , 2014, The Journal of clinical endocrinology and metabolism.

[76]  Michael E. Miller,et al.  Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. , 2014, JAMA.

[77]  R. Wirth,et al.  Prevalence of sarcopenia in geriatric hospitalized patients. , 2014, Journal of the American Medical Directors Association.

[78]  S. Bandinelli,et al.  Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[79]  Maren S Fragala,et al.  An Evidence-Based Comparison of Operational Criteria for the Presence of Sarcopenia , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[80]  Maren S Fragala,et al.  The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[81]  H. Makizako,et al.  Using two different algorithms to determine the prevalence of sarcopenia , 2014, Geriatrics & gerontology international.

[82]  L. Peng,et al.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. , 2014, Journal of the American Medical Directors Association.

[83]  J. Dalton,et al.  Selective androgen receptor modulators for the treatment of late onset male hypogonadism , 2014, Asian journal of andrology.

[84]  J. Morley,et al.  A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people , 2014, The journal of nutrition, health & aging.

[85]  M. Narici,et al.  Diagnostic criteria for sarcopenia and physical performance , 2014, AGE.

[86]  M. Yamada,et al.  Prevalence of sarcopenia in community-dwelling Japanese older adults. , 2013, Journal of the American Medical Directors Association.

[87]  M. Holick.  Bioavailability of vitamin D and its metabolites in black and white adults. , 2013, The New England journal of medicine.

[88]  M. Kim,et al.  Accuracy of segmental multi-frequency bioelectrical impedance analysis for assessing whole-body and appendicular fat mass and lean soft tissue mass in frail women aged 75 years and older , 2013, European Journal of Clinical Nutrition.

[89]  J. Morley,et al.  Frailty, sarcopenia, and hormones. , 2013, Endocrinology and metabolism clinics of North America.

[90]  D. Papanicolaou,et al.  A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia , 2013, The journal of nutrition, health & aging.

[91]  Takao Suzuki,et al.  Effects of exercise and tea catechins on muscle mass, strength and walking ability in community‐dwelling elderly Japanese sarcopenic women: A randomized controlled trial , 2013, Geriatrics & gerontology international.

[92]  A. Dobs,et al.  Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. , 2013, The Lancet. Oncology.

[93]  Ravi Kumar,et al.  A single ascending‐dose study of muscle regulator ace‐031 in healthy volunteers , 2013, Muscle & nerve.

[94]  G. Onder,et al.  Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. , 2013, Age and ageing.

[95]  M. Cesari,et al.  RECOMMENDATIONS FROM THE INTERNATIONAL WORKING GROUP ON SARCOPENIA , 2013 .

[96]  P. Shekelle,et al.  Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations , 2012, Implementation Science.

[97]  Hisamine Kobayashi,et al.  Effects of Exercise and Amino Acid Supplementation on Body Composition and Physical Function in Community‐Dwelling Elderly Japanese Sarcopenic Women: A Randomized Controlled Trial , 2012, Journal of the American Geriatrics Society.

[98]  G. Onder,et al.  Prevalence and risk factors of sarcopenia among nursing home older residents. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[99]  J. Dalton,et al.  The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial , 2011, Journal of cachexia, sarcopenia and muscle.

[100]  I. Rosenberg.  Sarcopenia: origins and clinical relevance. , 2011, Clinics in geriatric medicine.

[101]  Sandrine Andrieu,et al.  Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. , 2011, Journal of the American Medical Directors Association.

[102]  Michelle E. Kho,et al.  AGREE II: advancing guideline development, reporting and evaluation in health care , 2010, Canadian Medical Association Journal.

[103]  Stephan von Haehling,et al.  An overview of sarcopenia: facts and numbers on prevalence and clinical impact , 2010, Journal of cachexia, sarcopenia and muscle.

[104]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[105]  A. Pestronk,et al.  A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy , 2008, Annals of neurology.

[106]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[107]  K. Yarasheski,et al.  Effects of progressive resistance training on body composition in frail older adults: results of a randomized, controlled trial. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[108]  B. Tracy,et al.  Resistance and functional training reduces knee extensor position fluctuations in functionally limited older adults , 2005, European Journal of Applied Physiology.

[109]  A. Lenzi,et al.  Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle‐aged men: a meta‐analysis , 2005, Clinical endocrinology.

[110]  J. Morley,et al.  The hormonal fountains of youth: myth or reality? , 2005, Journal of endocrinological investigation.

[111]  E. Barrett-Connor,et al.  Sarcopenia in elderly men and women: the Rancho Bernardo study. , 2003, American journal of preventive medicine.

[112]  J. Sorkin,et al.  Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. , 2002 .

[113]  Robert Ross,et al.  Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability , 2002, Journal of the American Geriatrics Society.

[114]  R. Baumgartner,et al.  Predictors of skeletal muscle mass in elderly men and women , 1999, Mechanisms of Ageing and Development.

[115]  J. Morley,et al.  The Effect of Recombinant Human Growth Hormone on Malnourished Older Individuals , 1991, Journal of the American Geriatrics Society.